Search research articles
Contact Us
Filters
Showing results (201-210 of 221) with videos related to
Page
of 23
Sort By:
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
Molecular Cancer Therapeutics
|
July 22, 2016
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth
Michele C Smith, Mary M Mader, James A Cook, et al.
BMC Infectious Diseases
|
March 14, 2025
Lack of evidence for HEV infection in Baltic sea mussels (Mytilidae)
M Rastar-Tangeten, M Mader, S Schmiedel, et al.
Scientific Reports
|
August 20, 2024
Serological indication of chronic inflammatory demyelinating polyneuropathy as an extrahepatic manifestation of hepatitis E virus infection
S Pischke, A Kjasimov, T Skripuletz, et al.
Chemical Science
|
October 27, 2021
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake <i>in vivo</i>
Hemma Schueffl, Sarah Theiner, Gerrit Hermann, et al.
Nature Communications
|
June 10, 2022
Dendritic crystallization in hydrous basaltic magmas controls magma mobility within the Earth's crust
Fabio Arzilli, Margherita Polacci, Giuseppe La Spina, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
Neurobiology of Aging
|
April 10, 2007
Creatine improves health and survival of mice
A Bender, J Beckers, I Schneider, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Acyl sulfonamide anti-proliferatives. Part 2: activity of heterocyclic sulfonamide derivatives
Mary M Mader, Chuan Shih, Eileen Considine, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors
James L Douthwaite, Damian J Houde, Eneida Pardo, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 221) with videos related to
Sort By:
Page
of 23
British Journal of Cancer
|
January 12, 2012
Brain metastases free survival differs between breast cancer subtypes
A Berghoff, Z Bago-Horvath, C De Vries, et al.
Molecular Cancer Therapeutics
|
July 22, 2016
Characterization of LY3023414, a Novel PI3K/mTOR Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth
Michele C Smith, Mary M Mader, James A Cook, et al.
BMC Infectious Diseases
|
March 14, 2025
Lack of evidence for HEV infection in Baltic sea mussels (Mytilidae)
M Rastar-Tangeten, M Mader, S Schmiedel, et al.
Scientific Reports
|
August 20, 2024
Serological indication of chronic inflammatory demyelinating polyneuropathy as an extrahepatic manifestation of hepatitis E virus infection
S Pischke, A Kjasimov, T Skripuletz, et al.
Chemical Science
|
October 27, 2021
Albumin-targeting of an oxaliplatin-releasing platinum(iv) prodrug results in pronounced anticancer activity due to endocytotic drug uptake <i>in vivo</i>
Hemma Schueffl, Sarah Theiner, Gerrit Hermann, et al.
Nature Communications
|
June 10, 2022
Dendritic crystallization in hydrous basaltic magmas controls magma mobility within the Earth's crust
Fabio Arzilli, Margherita Polacci, Giuseppe La Spina, et al.
ACS Medicinal Chemistry Letters
|
July 24, 2018
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity
Zahid Q Bonday, Guillermo S Cortez, Michael J Grogan, et al.
Neurobiology of Aging
|
April 10, 2007
Creatine improves health and survival of mice
A Bender, J Beckers, I Schneider, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 25, 2005
Acyl sulfonamide anti-proliferatives. Part 2: activity of heterocyclic sulfonamide derivatives
Mary M Mader, Chuan Shih, Eileen Considine, et al.
Journal of Medicinal Chemistry
|
April 9, 2026
Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors
James L Douthwaite, Damian J Houde, Eneida Pardo, et al.
Page
of 23